Market Cap 34.66M
Revenue (ttm) 60,000.00
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18,566.67%
Debt to Equity Ratio 0.00
Volume 432,100
Avg Vol 1,584,768
Day's Range N/A - N/A
Shares Out 10.66M
Stochastic %K 16%
Beta 1.15
Analysts Strong Sell
Price Target $13.00

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which...

Industry: Biotechnology
Sector: Healthcare
Phone: 256 327 9630
Address:
601 Genome Way, Suite 2001, Huntsville, United States
jheerdink
jheerdink Feb. 3 at 2:05 PM
$SER register for Feb.4 Tribe Public Serina Therapeutics Webinare Event at 11:30am et at http://New-FDA-Era.TribePublic.com
0 · Reply
VMAESA
VMAESA Feb. 2 at 10:56 PM
$SER 500% in a year 😵‍💫
1 · Reply
ghcb1981
ghcb1981 Feb. 2 at 6:16 PM
0 · Reply
John_week
John_week Feb. 2 at 4:00 PM
$SER CTB thru the roof
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 2 at 2:03 PM
$SER (-18.8% pre) Form S-3 Serina Therapeutics https://ooc.bz/l/91595
0 · Reply
BryanGreenwater
BryanGreenwater Feb. 2 at 1:58 PM
$SER Buying the dip
0 · Reply
Donniechen12345
Donniechen12345 Feb. 2 at 2:07 AM
$SER 7.7 million shares offering Ouch!!!!!!! expect this to drop to around $2-$2.25 soon…. donnie will be ready to go Long soon$$$$$$
1 · Reply
etrade
etrade Feb. 1 at 9:56 PM
$SER that was easy ;)
0 · Reply
EinsteinsEyes
EinsteinsEyes Jan. 31 at 6:07 AM
$SER fuck this stock, huh?
0 · Reply
Donniechen12345
Donniechen12345 Jan. 30 at 10:44 PM
$SER offering huh hmmmmm
0 · Reply
Latest News on SER
Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 29, 2025, 6:00 AM EDT - 10 months ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day


Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 15, 2025, 4:05 PM EST - 1 year ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary


AgeX Therapeutics Reports Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

AgeX Therapeutics Reports Third Quarter 2023 Financial Results


jheerdink
jheerdink Feb. 3 at 2:05 PM
$SER register for Feb.4 Tribe Public Serina Therapeutics Webinare Event at 11:30am et at http://New-FDA-Era.TribePublic.com
0 · Reply
VMAESA
VMAESA Feb. 2 at 10:56 PM
$SER 500% in a year 😵‍💫
1 · Reply
ghcb1981
ghcb1981 Feb. 2 at 6:16 PM
0 · Reply
John_week
John_week Feb. 2 at 4:00 PM
$SER CTB thru the roof
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 2 at 2:03 PM
$SER (-18.8% pre) Form S-3 Serina Therapeutics https://ooc.bz/l/91595
0 · Reply
BryanGreenwater
BryanGreenwater Feb. 2 at 1:58 PM
$SER Buying the dip
0 · Reply
Donniechen12345
Donniechen12345 Feb. 2 at 2:07 AM
$SER 7.7 million shares offering Ouch!!!!!!! expect this to drop to around $2-$2.25 soon…. donnie will be ready to go Long soon$$$$$$
1 · Reply
etrade
etrade Feb. 1 at 9:56 PM
$SER that was easy ;)
0 · Reply
EinsteinsEyes
EinsteinsEyes Jan. 31 at 6:07 AM
$SER fuck this stock, huh?
0 · Reply
Donniechen12345
Donniechen12345 Jan. 30 at 10:44 PM
$SER offering huh hmmmmm
0 · Reply
BryanGreenwater
BryanGreenwater Jan. 30 at 4:39 PM
$SER looking good
0 · Reply
BryanGreenwater
BryanGreenwater Jan. 30 at 3:12 PM
$SER accumulation
0 · Reply
EagleEye027
EagleEye027 Jan. 30 at 2:25 PM
$SER what we looking at for market open?
0 · Reply
trading_momentum_x
trading_momentum_x Jan. 30 at 11:28 AM
$SER – 30m window SER broke out strong but is now sitting right on top of its key cluster at 3.01. If bulls reclaim 3.14 and hold above 3.16, the move could continue toward 3.40. If it breaks down, 2.90 and 2.70 are the zones to watch. Levels to watch: Heavy supply: 3.01 to 3.16 Breakout level: 3.40 Support pullbacks: 2.90 then 2.70
0 · Reply
char13
char13 Jan. 30 at 10:59 AM
$SER went down today
0 · Reply
giscra
giscra Jan. 30 at 10:13 AM
$SER Tight range, low float—look for volume ignition to trigger the next move
0 · Reply
trading_insight
trading_insight Jan. 30 at 10:09 AM
$SER a nice gap up over resistance on news. Doesn't feel like there was enough volume today for continuation. Needs to get over 3.70.
0 · Reply
trading_momentum_x
trading_momentum_x Jan. 30 at 6:07 AM
$SER Momentum has cooled from overbought levels but remains elevated above its mid-range, indicating bullish conditions are intact despite consolidation. As long as price holds above $3.00–$3.10, SER can continue to base and attempt another push higher; a clean reclaim and acceptance above $3.60–$3.70 would reopen a move toward the supply zone highs. A loss of $2.90–$2.80 would weaken the setup and shift focus back toward deeper demand, but for now the bias favors consolidation with upside continuation risk still present.
1 · Reply
trading_momentum_x
trading_momentum_x Jan. 30 at 6:07 AM
$SER is trading around $3.31 after hours, pulling back from a recent spike into a weak-high supply zone near $3.90–$4.10. Structurally, the stock has shifted from a prolonged downtrend into a developing higher-low sequence, with price now holding above the rising green trend band and above the $2.50–$2.60 demand zone, which remains the key structural support. The recent pullback looks corrective rather than impulsive, suggesting this is a pause after a strong expansion leg rather than trend failure.
0 · Reply
Denis081981
Denis081981 Jan. 30 at 4:41 AM
$SER Sometimes I see this site so off with the reality that I’m about to start trading against to the larger percentage’s predictions! Is Stocktwist really a trustworthy or serious source to follow or guide the sentiment of the market?
0 · Reply
DavidScott
DavidScott Jan. 30 at 4:05 AM
On watch tomorrow (momentum) // Part 1 🔥📈📚 $SGN $GCTS $FEED $CATX $SER
1 · Reply
BryanGreenwater
BryanGreenwater Jan. 30 at 1:35 AM
$SER Premarket pump tomorrow
1 · Reply